Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ozempic Is Moving a Bunch of Stocks Wednesday Morning


Stock markets looked poised to continue their winning ways on Wednesday morning, as Stock index futures were higher across the board. Investors will get a look today at the latest thought process from the Federal Reserve when it releases the minutes of its most recent monetary policy committee meeting. They're hopeful that what they read will support the case for leaving interest rates alone when the central bank gathers for its next meeting.

A host of stocks in the healthcare sector made some big moves early Wednesday. News on the popular Ozempic treatment helped push shares of some companies higher, including Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY). However, not every company was as fortunate, as shareholders in DaVita (NYSE: DVA) and Fresenius Medical Care (NYSE: FMS) can attest. Here's what you need to know about Ozempic right now and why these companies' shares are reacting the way they are.

On the winning side, the pair of drug developers got a nice boost. Novo Nordisk shares were up almost 4% in premarket trading, while Eli Lilly added early 3% early Wednesday morning.

Continue reading


Source Fool.com

Fresenius SE & Co. KGaA Stock

€28.90
2.520%
There is an upward development for Fresenius SE & Co. KGaA compared to yesterday, with an increase of €0.71 (2.520%).

Like: 0
NVO
Share

Comments